Delivery Order SPE2DB20D2014-SPE2DB25FC65Q
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, valued at $1,862.88. This firm fixed-price delivery order, which concludes on July 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,824.80 for NovoLog Mix 70-30 FlexPen 3mL insulin pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $2,289.58 delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML insulin pens on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement under DLA's Medical Supply Chain operations. The award was issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a...
- The Defense Logistics Agency awarded a $1,003.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML insulin pens, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,405.80 for NovoLog 100 Unit/ML FlexPen 3ML, a insulin medication used in diabetes management. Issued on July 29, 2025, with an ultimate completion date of July 30, 2025, this firm fixed price delivery order represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $1,257.27 with a firm fixed price structure. The award, issued on July 30, 2025, represents a non-competitive delivery order with a completion date of July 31, 2025. This contract is a child award executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.70 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, using firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this delivery from its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $3,682.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 22, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. This delivery order executes under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,537.84 firm fixed price delivery order on July 29, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 30, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $1,514.61, with an ultimate completion date of July 31, 2025. This non-competitive delivery order represents a firm fixed price pharmaceutical supply transaction, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award was issued on July 30, 2025, as part of AmerisourceBergen's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC65QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,242.86 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML, a pre-filled insulin injection device used for diabetes management. The award, issued on August 5, 2025, carries a firm fixed price and an ultimate completion date of August 6, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates extensive experience fulfilling DLA medical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/5/25 |